Status:
COMPLETED
Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Meningitis, Meningococcal
Eligibility:
All Genders
7-10 years
Phase:
PHASE2
Brief Summary
Infant phase: To determine the safety of and production of antibodies by a group C meningococcal conjugate vaccine (MnCC), when given at 2, 3, and 4 months of age with routine vaccines. Booster phase...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy infants 7-10 weeks of age eligible to receive routine immunization
Exclusion
Key Trial Info
Start Date :
June 1 1997
Trial Type :
INTERVENTIONAL
End Date :
April 1 1998
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00314041
Start Date
June 1 1997
End Date
April 1 1998
Last Update
February 21 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.